Evidence map›Paper›PMID 25143783›Full record

ArticleInfectious agents and cancer2014

Prevalence of human papillomavirus infection and phylogenetic analysis of HPV-16 E6 variants among infected women from Northern Brazil.

Bruna Pedroso Tamegão-Lopes, Edivaldo Costa Sousa-Júnior, Fabio Passetti, Carlos Gil Ferreira, Wyller Alencar de Mello, Rodrigo Vellasco Duarte Silvestre

Open access · goldAbstract read
In one paragraph

Article in Infectious agents and cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Bruna Pedroso Tamegão-Lopes *Laboratório de Papilomavírus, Seção de virologia, Instituto Evandro Chagas, Rodovia BR 316 km 07, Ananindeua, Pará, Brazil.
Edivaldo Costa Sousa-JúniorLaboratório de Papilomavírus, Seção de virologia, Instituto Evandro Chagas, Rodovia BR 316 km 07, Ananindeua, Pará, Brazil.
Fabio PassettiInstituto Nacional de Câncer (INCA), Clinical Research Coordination, Rua André Cavalcanti, 37, 20231-050 Rio de Janeiro, RJ, Brazil.
Carlos Gil FerreiraInstituto Nacional de Câncer (INCA), Clinical Research Coordination, Rua André Cavalcanti, 37, 20231-050 Rio de Janeiro, RJ, Brazil.
Wyller Alencar de MelloLaboratório de Papilomavírus, Seção de virologia, Instituto Evandro Chagas, Rodovia BR 316 km 07, Ananindeua, Pará, Brazil.
Rodrigo Vellasco Duarte Silvestre *Laboratório de Papilomavírus, Seção de virologia, Instituto Evandro Chagas, Rodovia BR 316 km 07, Ananindeua, Pará, Brazil.
Instituto Evandro Chagas · BRInstituto Nacional do Câncer · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe main cause of cervical cancer in the world is high risks human papillomavirus infection (mainly represented by HPV-16 and HPV-18), that are associated to the development of malign transformation of the epithelium. HPV prevalence exhibits a wide geographical variability and HPV-16 variants have been related to an increased risk of developing cervical intraepithelial lesion. The aim of this study was to describe DNA-HPV prevalence and HPV-16 variants among a women population from Northern Brazil.

methodsOne hundred and forty three women, during routine cervical cancer screening, at Juruti Project, fulfilled an epidemiological inquiry and were screened through a molecular HPV test. HPV-16 variants were determined by sequencing the HPV-16 E6 open reading frame.

resultsForty two samples were considered HPV positive (29.4%). None of those had abnormal cytology results. HPV prevalence varied between different age groups (Z(U) = 14.62; p = <0.0001) and high-risk HPVs were more frequent among younger ages. The most prevalent type was HPV-16 (14%) and it variants were classified, predominantly, as European (87.5%).

conclusionsHPV prevalence in our population was higher than described by others and the most prevalent HPV types were high-risk HPVs. The European HPV-16 variant was the most prevalent among HPV-16 positive samples. Our study reinforces the fact that women with normal cytology and a positive molecular test for high-risk HPVs should be submitted to continuous follow up, in order to verify persistence of infection, promoting an early diagnosis of cervical cancer and/or its precursors.

Indexed as

HPVHPV-16PrevalenceVariants

Identifiers

PMID25143783
PMCPMC4138943
OpenAlexW2099966519

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.